Pfizer Launches Expanded Access Program For CCR5 Antagonist Maraviroc
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer will begin enrolling HIV patients in the next “few months” and will recruit investigators that have not previously worked in expanded access.